Frankfurt - Delayed Quote • EUR Mauna Kea Technologies SA (1MK.F) Follow Add holdings 0.0961 -0.0151 (-13.58%) At close: June 13 at 8:12:07 AM GMT+2 Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure Undo Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for 1MK.F 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: 1MK.F View More All News Press Releases SEC Filings Mauna Kea Technologies: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital Mauna Kea Technologies Announces Results of Its Combined General Meeting of June 5, 2025 Mauna Kea Technologies Announces Major AI Breakthrough with Cellvizio in Pancreatic Cystic Lesion Risk Stratification Mauna Kea Technologies Provides Update on Safeguard Proceedings, Strategic Discussions and Operational Progress Mauna Kea Technologies Announces the Availability of Preparatory Documents for the Combined General Meeting of June 5, 2025 and the Instructions for Participation Mauna Kea Technologies Announces Largest Annual Pancreatic Cyst Consortium at Digestive Disease Week® 2025 Mauna Kea Technologies: Publication of the 2024 Annual Financial Report Mauna Kea Technologies Announces Another Milestone Year at Digestive Disease Week® 2025 with 8 Presentations Demonstrating the Clinical Value of Cellvizio® in Key Indications Mauna Kea Technologies Reports Full Year 2024 Results and Provides a Business Update Mauna Kea Technologies Announces Entrance Into Exclusive Negotiations for a Licensing Agreement for Cellvizio® in an Important Therapeutic Area With a Major Industry Player Mauna Kea Technologies Announces the Opening of a Safeguard Proceeding to Restructure Its Financial Liabilities